HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David R Sibley Selected Research

Dopamine D5 Receptors

3/2020Publisher Correction: The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.
1/2020The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.
1/2011Lack of renal dopamine D5 receptors promotes hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David R Sibley Research Topics

Disease

8Hypertension (High Blood Pressure)
06/2021 - 08/2004
6Substance-Related Disorders (Drug Abuse)
10/2022 - 10/2012
4Schizophrenia (Dementia Praecox)
10/2021 - 08/2003
2Dyskinesias (Dyskinesia)
03/2020 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
11/2019 - 10/2018
2Essential Hypertension
08/2004 - 12/2002
1Treatment-Resistant Depressive Disorder
11/2021
1Glioma (Gliomas)
10/2021
1Neoplasms (Cancer)
10/2021
1Neurocognitive Disorders (Clerambault Syndrome)
01/2021
1Alcoholism (Alcohol Abuse)
10/2019
1Parkinson Disease (Parkinson's Disease)
01/2018
1Whooping Cough (Pertussis)
08/2013
1Cocaine-Related Disorders (Cocaine Addiction)
03/2013
1Hypertrophy
01/2011
1Atrophy
01/2011
1Atrophic Muscular Disorders
01/2011
1Seizures (Absence Seizure)
06/2008

Drug/Important Bio-Agent (IBA)

11Dopamine Receptors (Dopamine Receptor)IBA
10/2021 - 12/2002
5Dopamine (Intropin)FDA LinkGeneric
01/2018 - 08/2004
3Pharmaceutical PreparationsIBA
10/2020 - 09/2015
3Dopamine D5 ReceptorsIBA
03/2020 - 01/2011
2Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021 - 05/2007
2Levodopa (L Dopa)FDA LinkGeneric
03/2020 - 01/2020
2Cholinergic Agents (Cholinergics)IBA
03/2020 - 01/2020
2Antipsychotic Agents (Antipsychotics)IBA
01/2018 - 08/2003
2SodiumIBA
06/2010 - 08/2004
1KetamineFDA LinkGeneric
10/2022
16-hydroxynorketamineIBA
10/2022
1EsketamineIBA
11/2021
1TIC10 compoundIBA
10/2021
1Oxidopamine (6 Hydroxydopamine)IBA
01/2020
1LigandsIBA
11/2019
1Hypnotics and Sedatives (Sedatives)IBA
10/2019
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2019
1Cholera ToxinIBA
08/2013
1CalciumIBA
08/2013
1Buspirone (Buspar)FDA LinkGeneric
03/2013
1Cocaine (Cocaine HCl)IBA
10/2012
1Dopamine D3 ReceptorsIBA
10/2012
1Methamphetamine (Desoxyn)FDA LinkGeneric
10/2012
1SK&F 81297IBA
01/2011
13- allyl- 6- chloro- 7,8- dihydroxy- 1- (3- methylphenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepineIBA
06/2008
1ConvulsantsIBA
06/2008
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
06/2008
1Type C PhospholipasesIBA
06/2008
18-epi-prostaglandin F2alphaIBA
05/2007
1NADPH Oxidases (NAD(P)H oxidase)IBA
05/2007
1tempolIBA
05/2007
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
05/2007
11-dodecylpyridoxal (PLD)IBA
01/2005
1Protein Isoforms (Isoforms)IBA
01/2005
1G-Protein-Coupled Receptor KinasesIBA
08/2004
1Vasopressins (Vasopressin)IBA
08/2004
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2004
1GTP-Binding Proteins (G-Protein)IBA
08/2004
1SaltsIBA
08/2004
1Oxytocin (Pitocin)FDA LinkGeneric
08/2004
1Serine (L-Serine)FDA Link
08/2004

Therapy/Procedure

2Self Administration (Administration, Self)
09/2015 - 10/2012
1Therapeutics
01/2018
1Drug Therapy (Chemotherapy)
03/2013